Skip to content
Precision for Medicine

Announcing the Institute@Precision, a Collaborative Forum for Biopharma Innovation.

AdobeStock_302075059 AdobeStock_302075059

See Beyond the Keyhole with RBQM Clinical Trials

Increase data integrity with our expert scientific and analytics data review teams
The Clinical Science & Centralized Monitoring  experts at Precision redefines data integrity through a fusion of scientific expertise and cutting-edge analytics. Powered by our proprietary platform, Clinscope, we deliver a smarter, more agile approach to risk-based quality management—one that prioritizes what matters most: critical data, patient safety, and regulatory confidence.
Tumor_data

Precision’s RBQM Clinical Trials Framework is Built for What’s Next

Streamline your clinical journey, enhance efficiency and accelerate your path to success with expert data integration, analysis, and interpretation.

Using an integrated model that shifts away from traditional monitoring, we replace exhaustive reviews with targeted, insight-rich analysis.

  • 50+ pre-built dashboards tailored for rapid insight and therapeutic relevance
  • Clinscope-powered centralized monitoring detects outliers, trends, and site-level risks with precision
  • Therapeutic-specific standards (RECIST v1.1, iRECIST, IMWG, Lugano, etc.) ensure consistency and accuracy
  • Proprietary data visualization tools allow for highly focused strategic reviews, catching complex issues beyond programmed edits
  • Proactive tech-enabled alerts flag complex data quality issues before they escalate
  • Cross-functional collaboration across Medical, Biostats, Data Management, and Clinical Ops ensures holistic data integrity
  • Real-time analytics drive quality outcomes and support pivotal trial decisions

By leveraging therapeutic expertise and real-time data visualization, complex trial data transforms into actionable intelligence to accelerate timelines and empower smarter decisions across the study lifecycle.

20 Avg. years research experience
15 Avg. years oncology experience
20 Global team members
8 Avg. years with Precision

Lifecycle RBQM Support From Start-Up to Submission

Our Clinical Science & Centralized Monitoring team combines scientific rigor with scalable innovation. With decades of therapeutic experience and global reach, we apply risk-based quality management (RBQM) and centralized monitoring to ensure data fidelity from study start-up through database lock. Powered by Clinscope visualization tools and therapeutic-specific standards, every stage of your trial is guided by clarity, confidence, and control.

  • Start-Up

    Start-Up

    Aligning data capture with protocol and therapeutic standards

    Our experts ensure the study design is built on a solid foundation for data precision.

  • Conduct

    Conduct

    Centralized, holistic, therapeutic data review

    Dashboards and real-time analytics highlight site-level risks while expert reviewers identify issues standard checks miss.

  • Risk Mitigation

    Risk Mitigation

    Proactive alerts and cross-functional collaboration

    Tech-enabled signals flag issues before they escalate, supported by Medical, Biostats, Data Management, and Clinical Ops teams.

  • Lock

    Lock

    On-time, confident database lock

    Continuous centralized review streamlines final medical review and prepares submission-ready datasets.

Insights from Precision’s experts

Stay ahead with the latest insights from Precision’s team of experts. Discover valuable perspectives, updates, and strategies to navigate early and late phase development.  

Read: Biomarker-Driven Clinical Trials in Oncology: Enrichment, Stratification, All-Comers & Basket Biomarker-Driven Clinical Trials in Oncology: Enrichment, Stratification, All-Comers & Basket

Biomarkers

Biomarker-Driven Clinical Trials in Oncology: Enrichment, Stratification, All-Comers & Basket

|
    has not third author: true, (SizeLimitingPyMap: {main={hs_id=199138167916, hs_child_table_id=0, hs_updated_at=1762375981786, hs_published_at=1762376754681, avatar=Image{width=800,height=800,url='https://5014803.fs1.hubspotusercontent-na1.net/hubfs/5014803/Paul%20Steven.png',altText='Paul Steven',fileId=199144298570}, lastname=Steven, hs_initial_published_at=1762375986271, hs_created_by_user_id=26433386, hs_created_at=1762375951865, hs_is_edited=false, hs_deleted_at=0, name=Paul, job=Principal Biostatistician, slug=paul-steven, hs_updated_by_user_id=26433386}, second={}, third={}})
  • Paul Steven avatar

    Paul Steven

Discover
Read: Investor Relations, Clinical Operations, and the Future of Biotech Financing Investor Relations, Clinical Operations, and the Future of Biotech Financing

Clinical Trials - Translational Research - Early Phase Research

Investor Relations, Clinical Operations, and the Future of Biotech Financing

|
    has not third author: true, (SizeLimitingPyMap: {main={hs_id=164725548862, hs_child_table_id=0, hs_updated_at=1716454315513, hs_published_at=1762376754681, description=Teresa is a respected business development strategist, building successful clinical programs for clients in Massachusetts. She is an innovator of fresh approaches to biomarker planning, translational solutions, and clinical study design. Her experience spans the execution of Phase 1-4 clinical trials, specialty lab services, companion and in vitro diagnostic strategies, and biomarker data management., avatar=Image{width=700,height=700,url='https://5014803.fs1.hubspotusercontent-na1.net/hubfs/5014803/PfM%20Website/Headshots/Headshots%20no%20background/Teresa-Pokladowski-300x300.png',altText='Teresa-Pokladowski-300x300',fileId=168135942975}, linkedin=https://www.linkedin.com/in/teresapokladowski/, lastname=Pokladowski, hs_initial_published_at=1713363230550, hs_created_by_user_id=5166971, hs_created_at=1713362443509, hs_is_edited=false, hs_deleted_at=0, name=Teresa, job=Regional Vice President, Clinical Business Solutions, North America, slug=teresa-pokladowski, hs_updated_by_user_id=26433386}, second={hs_id=197608580658, hs_child_table_id=0, hs_updated_at=1760465121471, hs_published_at=1762376754681, description=Hannah Dereseiwicz is a strategic force in investor relations, helping biotech innovators translate complex science into compelling narratives that drive engagement and growth. With a track record spanning commercial launches, M&A activity, and high-stakes communications, she brings clarity, confidence, and momentum to every stage of a company’s journey. Hannah’s approach is defined by the three A’s—ambitious, approachable, and authentic—making her a trusted partner for teams looking to elevate their story and connect with the audiences that matter most., avatar=Image{width=636,height=476,url='https://5014803.fs1.hubspotusercontent-na1.net/hubfs/5014803/Hannah%20Deresiewicz.webp',altText='Hannah Deresiewicz',fileId=197608718507}, lastname=Deresiewicz, hs_initial_published_at=1760465283803, hs_created_by_user_id=26433386, hs_created_at=1760464991513, hs_is_edited=false, hs_deleted_at=0, name=Hannah, job=Executive Vice President, Managing Director Precision AQ – Investor Relations & External Communications, slug=hannah-deresiewicz, hs_updated_by_user_id=26433386}, third={}})
  • Teresa P. avatar

    Teresa P.

  • Hannah D. avatar

    Hannah D.

Discover
Read: Clinical Trial Trends: Gene Therapy Clinical Trial Trends: Gene Therapy

Clinical Trials - Gene Therapies

Clinical Trial Trends: Gene Therapy

|
    has not third author: true, (SizeLimitingPyMap: {main={hs_id=164725548848, hs_child_table_id=0, hs_updated_at=1754641451547, hs_published_at=1762376754681, description=Alexis Hobbins-White is an accomplished leader who plays a pivotal role in navigating the complex landscape of global oncology and rare disease-focused clinical trials. With a career spanning over 15 years in the clinical trials industry, Alexis brings a wealth of experience across multiple therapeutic areas, showcasing her proficiency in diverse aspects of operational strategy. She specializes in early phase adaptive studies, particularly in immuno-oncology and advanced therapeutics. She has an MSc in Neuroscience and an MA in Biotechnology Law and Ethics., avatar=Image{width=287,height=287,url='https://5014803.fs1.hubspotusercontent-na1.net/hubfs/5014803/PfM%20Website/PfMxMarkentive/authors/Alexis-Hobbins.png',altText='Alexis-Hobbins',fileId=194096322982}, linkedin=https://www.linkedin.com/in/alexis-hobbins-white-400a1720/, lastname=Hobbins-White, hs_initial_published_at=1713362276020, hs_created_by_user_id=5166971, hs_created_at=1713361952861, hs_is_edited=false, hs_deleted_at=0, name=Alexis, job=Senior Director, Operational Strategy , slug=alexis-hobbins-white, hs_updated_by_user_id=26433386}, second={}, third={}})
  • Alexis Hobbins-White avatar

    Alexis Hobbins-White

Discover

Delivering Clinical Success Across Phases

  • Clinical Development Strategy

    Unlock the full potential of your clinical trials with our tailored Clinical Development Strategies. Designed to navigate the complexities of trial execution, Precision can propel your program toward accelerated success.

    Services Offered: 


    • Clinical Development Planning
    • Clinical Trial Design
    • Biomarker Trial Strategies
    • Basket, Master & Umbrella trials

    →LEARN MORE

    Clincal-dvp
  • Full-Service CRO

    Experience seamless integration and meticulous management of your clinical trial with our Full-Service CRO. We ensure every detail is managed with expertise to drive your study towards its successful completion.

    Services include, but are not limited to: 


    • Full-service Study Management
    • Study Start-up & Feasibility
    • Clinical Monitoring
    • Medical Monitoring
    • Drug Safety & Pharmacovigilance
    • Data Management
    • Biostatistics

    →LEARN MORE

    CRO
  • Precision FSP

    Amplify your clinical trial efficiency with Precision’s Functional Service Provider (FSP) solutions, offering specialized support focused on your project's unique needs.

    Solutions Offered:


    • FSP Clinical Monitoring
    • FSP Drug Safety & Pharmacovigilance
    • FSP Data Management
    • FSP Biostatistics
    • FSP Statistical Programming
    • FSP Medical Writing

    →LEARN MORE

    FSP

Advance therapeutic breakthroughs with Precision

Explore the breadth of our expertise in therapeutics and modalities, as we lead your novel treatments in Oncology, Rare Diseases and beyond, from the groundbreaking idea to clinical realization.

Specialized capabilities in every stage of clinical development

Leverage an integrated infrastructure that reduces the inefficiencies inherent in complex development. Integrate lab and trial execution to accelerate speed to market. Precision can customize and converge our capabilities to meet your program's unique needs—driving efficiency, agility, and success from start to finish.

  • Discover Explore
    clinical-trial-support

    Global CRO
    Services

    Award-winning CRO with deep oncology and rare disease expertise

    Explore
  • Discover Explore
    specialty-lab-services

    Global Laboratory
    Services

    Exceptional translational and biomarker sciences with global central lab services

    Explore